A bill to amend title XI of the Social Security Act to require that direct-to-consumer advertisements for prescription drugs and biological products include truthful and non-misleading pricing information.
About This Bill
Committee
Latest Action · May 13, 2019
Read twice and referred to the Committee on Finance. (text: CR S2791)